Search - tctmd.com

Displaying 361 - 380 of 430

Sort: Relevancy | Date

News Industry News

Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio

July 15, 2013

News Industry News

St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D

June 24, 2013

Presentation TVT 2013

Why Does TAVR Cost So Much? Perspectives from the Medical Device Industry

Presenter: Larry Wood

June 13, 2013

News Industry News

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

May 06, 2013

News Daily News

Self-Reported Financial Conflicts Have No Effect on Cardiovascular Trial Outcomes

Caitlin E. Cox

February 07, 2013

News Conference News TCT 2012

TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons

October 26, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

October 24, 2012

News Conference News TCT 2012

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

October 23, 2012

News Industry News

Boston Scientific to Acquire BridgePoint Medical, Inc.

September 19, 2012

News Conference News ESC 2012

French, European Registries Add International Flavor to TAVR Assessment

August 29, 2012

News Daily News

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

Jason Kahn

July 31, 2012

News Industry News

St. Jude Medical Announces Japanese Launch of Industry's First Small Quadripolar Technology to Treat Heart Failure

July 17, 2012

News Industry News

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

July 16, 2012

News Industry News

Cardiosolutions, Inc. Gathers Major Investment from Sorin Group

July 10, 2012

News Industry News

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

July 02, 2012

News Industry News

St. Jude Medical Announces FDA Clearance of the AMPLATZER Vascular Plug 4

June 18, 2012

News Industry News

Hansen Medical Receives FDA 510(k) Clearance for its Magellan™ Robotic System for Peripheral Vascular Interventions

June 04, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

Advertisement

Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio

St. Jude Medical Receives CE Mark Approval of MultiPoint Pacing CRT-D

Why Does TAVR Cost So Much? Perspectives from the Medical Device Industry

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

Self-Reported Financial Conflicts Have No Effect on Cardiovascular Trial Outcomes

TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach

Boston Scientific to Acquire BridgePoint Medical, Inc.

French, European Registries Add International Flavor to TAVR Assessment

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

St. Jude Medical Announces Japanese Launch of Industry's First Small Quadripolar Technology to Treat Heart Failure

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

Cardiosolutions, Inc. Gathers Major Investment from Sorin Group

PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital

St. Jude Medical Announces FDA Clearance of the AMPLATZER Vascular Plug 4

Hansen Medical Receives FDA 510(k) Clearance for its Magellan™ Robotic System for Peripheral Vascular Interventions

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content